Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study
Huang, C.-Y.; Chen, G.-Y.; Shieh, M.-L.; Li, H.-Y. Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study. Life 2020, 10, 90. https://doi.org/10.3390/life10060090
Huang C-Y, Chen G-Y, Shieh M-L, Li H-Y. Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study. Life. 2020; 10(6):90. https://doi.org/10.3390/life10060090
Chicago/Turabian StyleHuang, Chen-Yu, Guan-Yeu Chen, Miawh-Lirng Shieh, and Hsin-Yang Li. 2020. "Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study" Life 10, no. 6: 90. https://doi.org/10.3390/life10060090

